Skip to main content

Table 4 EGFR and HER2 copy number alterations

From: Correlations of EGFR mutations and increases in EGFR and HER2 copy number to gefitinib response in a retrospective analysis of lung cancer patients

#

Sex

Ethnicity

Smoking Status

Histology

Source Tissue

Block Type1

Response2

EGFR Mutation

EGFR/CEP7

HER2/CEP17

EGFR Stratification3

HER2 Stratification3

9

F

Asian

N

adeno.

Cerebellum

Tissue Block

SD

Not Sequenced

2.1

1.9

High Poly.

Low Poly.

11

F

Asian

Unk.

adeno.

Lung

Tissue Block

PR

Exon 19 Del*, Exon 20 V774L

2.7

1.5

High Poly.

High Trisomy

27

F

Caucasian

Y

SCC

Lung

Tissue Block

PD

None

2.1

1.5

High Poly.

Low Poly.

34

M

Caucasian

Y

SCC

Lung

Tissue Block

SD

None

17.3

2.6

Gene Amp.

High Poly.

36

M

Asian

Y

adeno.

Pleura

Tissue Block

SD

None

2.0

2.0

Low Poly.

Low Poly.

40

M

Caucasian

Y

adeno.

Pleura

Cell Block

SD

None

3.1

1.4

High Poly.

Low Poly.

42

M

Caucasian

Y

adeno.

Lymph Node

Tissue Block

Unk.

None

2.1

2.3

Low Poly.

High Poly.

43

F

Caucasian

Y

adeno.

Lymph Node

Tissue Block

PD

None

2.7

0.9

High Poly.

Low Trisomy

44

F

Asian

N

adeno.

Pleura

Tissue Block

PR

Exon 20 S768I, Exon 20 L815L

1.9

2.9

Low Poly.

High Poly.

56

M

Caucasian

Y

adeno.

Lung

Tissue Block

Unk.

None

1.5

2.0

High Trisomy

Low Poly.

57

M

Caucasian

Y

adeno.

Lymph Node

Tissue Block

SD

None

1.6

2.2

Low Poly.

High Poly.

64

F

Caucasian

Y

         
   

Pre Rx:

adeno.

Lymph Node

Tissue Block

-

None

1.0

1.2

Low Trisomy

High Trisomy

   

Post Rx:

adeno.

Pericaridium

Tissue Block

SD

None

2.2

1.3

Low Poly.

Low Trisomy

66

F

Asian

N

adeno.

Lung

Tissue Block

PR

Exon 19 Del*

2.9

1.2

High Poly.

Low Trisomy

  1. Patient data provided for samples displaying increased EGFR or HER2 copy number (Probe/CEP ratio > 2.0) or identified as FISH+ (High Polysomy or Gene Amplification)
  2. * = no mutations detected in normal tissue remaining after microdissection
  3. 1 = source of patient material (Tissue Block = microdissected formalin-fixed paraffin-embedded tissue block; Cell Block = whole section or microdissected formalin-fixed paraffin-embedded cell block; Cytology = scraped cytology slide)
  4. 2 = response as measured radiographically and defined by SWOG modification of the WHO criteria [20].
  5. PD = progressive disease, SD = stable disease, PR = partial response, Unk. = Unknown
  6. 3 = Copy number stratification as proposed by Cappuzzo et al [13]. (Disomy = < 2 copies in > 90% of cells, Low Trisomy = ≤2 copies in ≥40% of cells, 3 copies in 10–40% of cells, ≥4 copies in < 10% of cells, High Trisomy = ≤2 copies in ≥40% of cells, 3 copes in ≥40% of cells, ≥4 copes in < 10% of cells, Low Polysomy: ≥4 copies in 10–40% of cells, High Polysomy = ≥4 copies in 40% of cells, Gene Amplification = ≥15 copies in ≥10% of cells)